SCHEMBL147625

SCHEMBL147625

COc1cc2ccccc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 3/20 0.46
TUBB P07437 3/20 0.46
TUBA3C P0DPH7 3/20 0.46
TUBA1B P68363 3/20 0.46
TUBA4A P68366 3/20 0.46
TUBB4B P68371 3/20 0.46
TUBB3 Q13509 3/20 0.46
TUBB2A Q13885 3/20 0.46
TUBB8 Q3ZCM7 3/20 0.46
TUBA3E Q6PEY2 3/20 0.46
TUBA1A Q71U36 3/20 0.46
TUBA1C Q9BQE3 3/20 0.46
TUBB6 Q9BUF5 3/20 0.46
TUBB2B Q9BVA1 3/20 0.46
TUBB1 Q9H4B7 3/20 0.46
CYP2A6 P11509 5/20 0.46
AGXT P21549 1/20 0.46
ADRB2 P07550 1/20 0.46
ASIC3 Q9UHC3 1/20 0.45
LOXL2 Q9Y4K0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17394561 0.81 AGXT (0.48) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL30385553 0.79 AGXT (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL20563717 0.78 CYP2A6 (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL919365 0.77 AGXT (0.46) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL5719122 0.77 AGXT (0.46) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1763599 0.76 AGXT (0.44) CYP2A6AGXTADRB2ASIC3LOXL2
SCHEMBL5198179 0.75 HDAC3 (0.49) CYP2A6CA12CA9BCL2L1CA2
SCHEMBL826722 0.74 CYP2A6 (0.52) CYP2A6CA2CYP1A2
SCHEMBL4580171 0.74 BACE1 (0.67) CYP2A6CA2CYP1A2
SCHEMBL29239834 0.74 CA2 (0.57) CYP2A6CA2CYP1A2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119264126-A Fluorescent probe based on methoxybenzothiophene derivative and preparation method and application thereof 济宁医学院 2025-01-07 CN claimed
EP-1644350-B1 SULFAMATE BENZOTHIOPHENE DERIVATIVES AS STEROID SULFATASE INHIBITORS THERAMEX (MC) 2009-07-01 EP claimed
US-7476691-B2 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors LABORATOIRE THERAMEX (MC) 2009-01-13 US claimed
US-20040116410-A1 Diazepinones as antiviral agents CHO HIDETSURA (JP) 2004-06-17 US claimed
WO-2002014324-A2 DIAZEPINONES AS ANTIVIRAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-02-21 WO claimed
EP-1121125-A1 PHARMACEUTICAL FORMULATIONS FOR USE IN ESTROGEN DEPRIVATION SYNDROME ELI LILLY AND COMPANY (US) 2001-08-08 EP claimed
WO-2000021535-A1 PHARMACEUTICAL FORMULATIONS FOR USE IN ESTROGEN DEPRIVATION SYNDROME ELI LILLY AND COMPANY (US) 2000-04-20 WO claimed
CN-119264126-B Fluorescent probe based on methoxybenzothiophene derivative and preparation method and application thereof 济宁医学院 2025-06-20 CN disclosed
CN-119264126-B Fluorescent probe based on methoxybenzothiophene derivative and preparation method and application thereof 济宁医学院 2025-06-20 CN disclosed
US-12275716-B2 Modulators of estrogen receptor proteolysis and associated methods of use ARVINAS OPERATIONS, INC. (US) 2025-04-15 US disclosed
CN-119661526-A Perylene imide compound and preparation method and application thereof 华东理工大学 2025-03-21 CN disclosed
US-20250092009-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2025-03-20 US disclosed
CN-119264126-A Fluorescent probe based on methoxybenzothiophene derivative and preparation method and application thereof 济宁医学院 2025-01-07 CN disclosed
WO-1997030985-A1 BENZOTHIOPHENES, AND FORMULATIONS AND METHODS, USING SAME ELI LILLY AND COMPANY (US) 1997-08-28 WO disclosed
WO-1997025033-A1 ANTITHROMBOTIC DIAMINES ELI LILLY AND COMPANY (US) 1997-07-17 WO disclosed
EP-0723537-A1 BENZOTHIOPHENES AND RELATED COMPOUNDS AS ESTROGEN AGONISTS PFIZER INC. (US) 1996-07-31 EP disclosed
US-5529864-A CONTAINING PHOTOCHROMIC DYE DISPERSED IN LIQUID CRYSTALLINE POLYMER CANON KABUSHIKI KAISHA (JP) 1996-06-25 US disclosed
US-5443940-A An alkoxybenzothiophene maleic anhydride or maleimide as photochromic dyes; photosensitivity, durability SANYO ELECTRIC CO., LTD. (JP) 1995-08-22 US disclosed
EP-0122153-A1 Improvements in or relating to the preparation of 3-benzothienylglycines ELI LILLY AND COMPANY (US) 1984-10-17 EP disclosed
US-4458085-A Preparation of 3-benzothienylglycines ELI LILLY AND COMPANY (US) 1984-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12275716-B2 Modulators of estrogen receptor proteolysis and associated methods of use ADRM1, MDM2, ESR2 TUBB4A 3970/4885TUBB 3422/4885TUBA3C 4460/4885
US-20250092009-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 TUBB4A 3724/4885TUBB 4089/4885TUBA3C 4392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.